Preliminary evaluation of the seven-item Explicit Stigmatizing Attitudes Toward People With Cancer Scale
This study presents the preliminary evaluation of a seven-item Polish-language scale (ESATC-7) for measuring explicit stigmatizing attitudes toward people with cancer, which demonstrated acceptable internal consistency and preliminary construct validity but requires further independent validation before broader clinical or research application.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Cancer is a disease that touches nearly every family, yet the social reaction to it can be as damaging as the illness itself. When people hear the word "cancer," they often feel fear, and sometimes that fear turns into a desire to keep their distance. This reaction, known as stigma, is not just about feeling sorry for someone; it is a set of beliefs that can lead to treating a person with cancer as if they are less worthy, dangerous, or responsible for their own suffering. This social distance can stop people from seeking medical help early, make them hide their diagnosis, and isolate them from the support they need. While researchers have studied how patients feel about this stigma, there has been a significant gap in understanding what the general public actually thinks. In Poland, for instance, there was no simple, tested tool to measure these explicit, negative attitudes held by ordinary people. Without a way to measure the problem, it is difficult to know how big it is or how to fix it.
A researcher at Andrzej Frycz Modrzewski Krakow University set out to build a tool to fill this gap. The goal was to create a short, clear questionnaire that could ask people directly if they believe in excluding or restricting the lives of those with cancer. The researcher started with a pool of ten questions designed to probe specific areas of life, such as whether a person with cancer should be allowed to work, rent an apartment, or have children. The study involved 326 adults recruited in Krakow, a group that was mostly young and female. The researcher asked them to read statements and decide how much they agreed with them, ranging from strong disagreement to strong agreement. The aim was to see which questions worked well together to measure a single idea: the willingness to endorse overt social exclusion.
The initial test revealed that not all the questions were working as intended. Two of the questions, which were phrased positively to see if people would agree with accepting cancer patients, actually confused the results. When the researcher looked at the data, these two positive questions moved in the opposite direction of the negative ones, suggesting they were not measuring the same underlying feeling. Another question was also removed because it did not fit well with the others after the first two were excluded. After carefully removing these three items, the researcher was left with a seven-question scale. This shorter version, called the ESATC-7, showed a strong internal consistency, meaning the seven questions reliably measured the same concept. The analysis confirmed that these seven items formed a dominant response tendency in this specific sample, though the study notes that the factor analysis does not by itself establish that the complete content domain of cancer stigma has been fully represented.
The results of this new scale painted a clear picture of the attitudes held by this specific group. A significant portion of the participants, nearly 13 percent, gave the lowest possible score, indicating they held no overtly stigmatizing views. However, a much larger group, nearly 30 percent, scored very close to that minimum, suggesting that while they might not be extreme in their views, they still leaned toward low levels of stigma. The study also looked at how these scores related to other beliefs. It found that people who believed lung cancer only affects smokers, or that most people contribute to their own disease, tended to have higher stigma scores. This connection makes sense, as blaming the patient often leads to a desire to distance oneself from them. Interestingly, the small group of participants who had personally experienced cancer or had a family member with the disease held significantly lower stigma scores than those without such experience. This suggests that direct contact with the illness can break down the barriers of fear and judgment.
Despite these promising findings, the researcher is careful to define what this tool can and cannot do. The study was conducted on a specific, non-representative group of young adults in one city, so the results cannot be generalized to the entire population of Poland. The tool is described as a candidate index, a preliminary step rather than a final, perfect solution. It has not yet been tested against other established measures of stigma, nor has it been checked to see if it gives the same results over time. The researcher notes that the scale is best used for exploring group trends in research settings, not for diagnosing individuals or making clinical decisions. The work serves as a vital foundation, providing the first Polish-language measure that can explicitly track how much the public agrees with excluding people with cancer. By identifying the specific questions that work and those that do not, this study offers a clear path forward for future research to better understand and eventually reduce the social burden of cancer.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.